Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE Study - PubMed
6 hours ago
- #NSCLC
- #Asia Pacific
- #Treatment Patterns
- The ELEVATE study examines treatment patterns for early stage NSCLC in Asia Pacific.
- 505 physicians were screened, with 212 eligible for the study across six territories.
- High-risk individuals were frequently screened, and biomarker testing was common.
- Treatment recommendations varied by disease stage and oncogenic alterations.
- Surgery followed by adjuvant chemotherapy was a common approach.
- Definitive concurrent chemoradiation and chemoradiation followed by immunotherapy were also recommended.
- Cisplatin was preferred over carboplatin for neoadjuvant and adjuvant therapies.
- Physicians were more likely to prescribe neoadjuvant or adjuvant treatments for patients with lower ECOG performance status and/or higher nodal stage.
- Variations in treatment patterns were observed among territories and specialties.
- The study highlights the need for region-specific guidelines to inform clinical practice.